Fluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion

Device Code: 5040

Product Code(s): NXG

Definition: Topoisomerase Ii Alpha (top2a) Fluorescence In Situ Hybridization (fish) Kit Is To Detect The Top2a Gene Copy Number Changes (amplification And Deletion) In Breast Cancer Using Formalin-fixed, Paraffin-embeded Human Breast Cancer Tissue Specimen.

Device Classification Information

Device Type ID5040
Device NameFluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion
Physical StateAssay Kit Contains Pre-treatment Solution, TOP2A/CEN-17 Probe Mix, Buffers, And Fluorescence Mounting Medium
Technical MethodFluorescence In Situ Hybridization, Manual Method
Target AreaFormalin-fixed, Paraffin-embeded Human Breast Cancer Tissue Specimen
Review PanelPathology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission TypePMA
FDA Device ClassificationClass 3 Medical Device
Product CodeNXG
GMP ExemptNo
Summary MRIneligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID5040
DeviceFluorescence In Situ Hybridization, Topoisomerase Ii Alpha, Gene Amplification And Deletion
Product CodeNXG
FDA Device ClassificationClass 3 Medical Device
TPLC Last Update: 2019-04-02 20:59:13

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.